Teva receives EU Marketing Authorisation for Seffalair® Spiromax® and BroPair® Spiromax® (salmeterol xinafoate / fluticasone propionate) | Business Wire
Package leaflet: Information for the user Budesonide Teva Pharma 0.5 mg/2 ml Nebuliser Suspension Budesonide Teva Pharma 1 mg/2
Budesonide Capsules Market Report | Global Forecast From 2022 To 2030
Budesonide Inhalation Suspension 0.5mg 2mL Inhaler 30/Bx - Henry Schein 340B Medical
Budesonide 0.25 mg/2ml 30X2 Ml Unit Dose By Teva Pharma.